P. Emery

1.1k total citations
60 papers, 680 citations indexed

About

P. Emery is a scholar working on Rheumatology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, P. Emery has authored 60 papers receiving a total of 680 indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Rheumatology, 16 papers in Radiology, Nuclear Medicine and Imaging and 14 papers in Immunology. Recurrent topics in P. Emery's work include Rheumatoid Arthritis Research and Therapies (34 papers), Systemic Lupus Erythematosus Research (18 papers) and Monoclonal and Polyclonal Antibodies Research (14 papers). P. Emery is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (34 papers), Systemic Lupus Erythematosus Research (18 papers) and Monoclonal and Polyclonal Antibodies Research (14 papers). P. Emery collaborates with scholars based in United Kingdom, Denmark and United States. P. Emery's co-authors include Andrew Gough, Aarnoud Huissoon, Phil Perkins, Richard J. Reece, R Holder, J Devlin, J. S. Smolen, Caroline Gordon, P. A. Bacon and C. Richardson and has published in prestigious journals such as The Lancet, Annals of the Rheumatic Diseases and Lara D. Veeken.

In The Last Decade

P. Emery

57 papers receiving 650 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
P. Emery United Kingdom	15	432	170	119	108	85	60	680
R. Rau Germany	11	428 1.0×	111 0.7×	165 1.4×	66 0.6×	56 0.7×	38	623
H. S. Goei Thè Netherlands	14	503 1.2×	159 0.9×	132 1.1×	31 0.3×	66 0.8×	29	720
Е Н Александрова Russia	11	374 0.9×	161 0.9×	106 0.9×	65 0.6×	88 1.0×	210	610
B Gömör Hungary	8	516 1.2×	161 0.9×	152 1.3×	32 0.3×	69 0.8×	27	666
S. Marzouk Tunisia	14	327 0.8×	255 1.5×	61 0.5×	64 0.6×	76 0.9×	94	652
P Hickling United Kingdom	13	440 1.0×	126 0.7×	139 1.2×	36 0.3×	63 0.7×	34	625
E. K. Li China	18	702 1.6×	427 2.5×	142 1.2×	87 0.8×	65 0.8×	23	934
Д. Е. Каратеев Russia	11	436 1.0×	188 1.1×	147 1.2×	78 0.7×	36 0.4×	174	667
Lihua Wu China	13	401 0.9×	350 2.1×	48 0.4×	110 1.0×	40 0.5×	28	825
Anna Södergren Sweden	12	588 1.4×	143 0.8×	94 0.8×	39 0.4×	46 0.5×	33	794

Countries citing papers authored by P. Emery

Since Specialization

Citations

This map shows the geographic impact of P. Emery's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Emery with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Emery more than expected).

Fields of papers citing papers by P. Emery

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Emery. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Emery. The network helps show where P. Emery may publish in the future.

Co-authorship network of co-authors of P. Emery

This figure shows the co-authorship network connecting the top 25 collaborators of P. Emery. A scholar is included among the top collaborators of P. Emery based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Emery. P. Emery is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Marco, Gabriele De, E. Hensor, Philip Helliwell, et al.. (2024). OP0184 A TREATMENT STRATEGY COMBINING TNF-INHIBITOR, METHOTREXATE AND STEROIDS IS NOT SUPERIOR TO METHOTREXATE AND STEROIDS IN EARLY PSORIATIC ARTHRITIS: RESULTS FROM THE GOLMEPSA RANDOMISED, DOUBLE-BLIND CLINICAL TRIAL. Annals of the Rheumatic Diseases. 83. 153–154. 1 indexed citations

Bowman, Simon, Colin Everett, Stefano Bombardieri, et al.. (2015). Preliminary Results of a Double-Blind Randomised Trial of Rituximab Anti-B-Cell Therapy in Patients with Primary Sjogrens Syndrome. White Rose Research Online (University of Leeds, The University of Sheffield, University of York). 12 indexed citations

Huizinga, T., Seán Connolly, Alyssa Johnsen, et al.. (2015). Effect of Anti-Cyclic Citrullinated Peptide 2 Immunoglobulin M Serostatus on Efficacy Outcomes Following Treatment with Abatacept Plus Methotrexate. Data Archiving and Networked Services (DANS). 67. 1 indexed citations

Huizinga, T., Seán Connolly, D E Furst, et al.. (2014). The Impact on Anti-Citrullinated Protein Antibody Isotypes and Epitope Fine Specificity in Patients with Early RA Treated with Abatacept and Methotrexate.. Data Archiving and Networked Services (DANS). 66. 4 indexed citations

Gabay, Cem, P. Emery, & Ronald van Vollenhoven. (2013). Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial (vol 381, pg 1541, 2013). The Lancet. 381(9877). 13 indexed citations

Emery, P., Dominique Baeten, Joachim Sieper, et al.. (2012). EVALUATION OF EFFICACY AND SAFETY OF SECUKINUMAB IN THE TREATMENT OF PATIENTS WITH MODERATE-TO-SEVERE ANKYLOSING SPONDYLITIS. Lara D. Veeken. 51. 21–21. 6 indexed citations

Hodgson, Richard, Andrew J. Grainger, Philip O’Connor, et al.. (2012). Quantitative MRI measurements of the Achilles tendon in spondyloarthritis using ultrashort echo times. British Journal of Radiology. 85(1015). e293–e299. 10 indexed citations

Weinblatt, M., R Fleischmann, Ronald van Vollenhoven, et al.. (2011). Efficacy and Safety of Certolizumab Pegol in a Broad Population of Patients with Active Rheumatoid Arthritis: Week 28 Results From a Phase IIIb Randomized Controlled Study. Data Archiving and Networked Services (DANS). 63(10). 2 indexed citations

Conaghan, Philip G., P. Emery, Mikkel Østergaard, et al.. (2011). Assessment of inflammation and damage by MRI in established RA patients with Methotrexate inadequate response receiving Golimumab: Results of the GO-FORWARD trial. Annals of the Rheumatic Diseases. 70. 2 indexed citations

10.

Huizinga, T., P. Emery, René Westhovens, et al.. (2011). Rate of Anti-Cyclic Citrullinated Peptide Antibody and Rheumatoid Factor Seroconversion in Patients with Undifferentiated Arthritis or Early Rheumatoid Arthritis Treated with Abatacept.. Data Archiving and Networked Services (DANS). 63(10). 2 indexed citations

11.

Emery, P., R. Fleischmann, Désirée van der Heijde, et al.. (2011). GOLIMUMAB AND RADIOGRAPHIC PROGRESSION IN RHEUMATOID ARTHRITIS: RESULTS OF GO-BEFORE AND GO-FORWARD STUDIES. Lara D. Veeken. 50. 119–120. 1 indexed citations

12.

Keystone, E., R. Fleischmann, J S Smolen, et al.. (2010). THE EFFICACY OF CERTOLIZUMAB PEGOL ADDED TO METHOTREXATE IS SUSTAINED OVER 2 YEARS IN THE TREATMENT OF RHEUMATOID ARTHRITIS. Lara D. Veeken. 49. 1 indexed citations

13.

Keen, Helen, Laura C. Coates, Patrick J. O’Connor, et al.. (2008). A randomized controlled trial of infliximab shows clinical and MRI efficacy in HLA B27 positive very early ankylosing spondylitis. Clinical and Experimental Rheumatology. 26. 745–745. 11 indexed citations

14.

Fleischmann, R, Patrick Durez, P. Emery, et al.. (2008). Golimumab, a new human Anti-TNF-alpha monoclonal antibody, administered subcutaneously everv 4 weeks in methotrexate-naive patients with active rheumatoid arthritis: A randomized, double-blind, placebo-controlled, GO-BEFORE study. DIAL (Catholic University of Leuven). 58(9). 4 indexed citations

15.

Fleischmann, R, et al.. (2005). Preliminary efficacy results of rituximab retreatment in patients with active rheumatoid arthritis. Queensland's institutional digital repository (The University of Queensland). 52(9). 7 indexed citations

16.

Snowden, John A., John J. Moore, Paul Cannell, et al.. (2001). Autologous stem cell transplantation in rheumatoid arthritis. eCite Digital Repository (University of Tasmania). 3 indexed citations

17.

Morgan, Ann W, G Hale, Stephen J. Richards, et al.. (1997). Combination therapy with a TNF antagonist and a CD4 monoclonal antibody in rheumatoid arthritis. A pilot study.. Oxford University Research Archive (ORA) (University of Oxford). 40. 305–305. 7 indexed citations

18.

Gough, Andrew, David Andrews, P. A. Bacon, & P. Emery. (1995). EVIDENCE OF OMEPRAZOLE-INDUCED SMALL BOWEL BACTERIAL OVERGROWTH IN PATIENTS WITH SCLERODERMA. Lara D. Veeken. 34(10). 976–977. 22 indexed citations

19.

Moots, Robert J., et al.. (1994). Liver disease in twins with Felty's syndrome.. Annals of the Rheumatic Diseases. 53(3). 202–205. 4 indexed citations

20.

Gough, Andrew, Jeff Faint, P Wordsworth, M Salmon, & P. Emery. (1992). THE HLA CLASS II ASSOCIATIONS OF RHEUMATOID-ARTHRITIS CONFER SEVERITY NOT SUSCEPTIBILITY. Oxford University Research Archive (ORA) (University of Oxford). 35. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact